Timber Hill’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Timber Hill’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-10,463	Closed	-$615K	–	1596
2017 Q1	$615K	Buy	10,463 +85	+0.8%	+$4.97K	﹤0.01%	1361
2016 Q4	$581K	Buy	10,378 +5,035	+94%	+$290K	﹤0.01%	1582
2016 Q3	$329K	Buy	+5,343	New	+$350K	﹤0.01%	1661

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return

Timber Hill's PJP Position: Q2 2017 in Review

Timber Hill sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2017, closing a stake of 10,463 shares — an estimated $615K sold.

Timber Hill first reported a position in PJP in Q3 2016 and held it in 3 quarters. The position peaked at $615K in Q1 2017. 99 funds tracked by Wall St. Rank hold PJP as of Q2 2017.

Timber Hill reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2017 after selling out during the quarter.
Timber Hill sold 10,463 Invesco Pharmaceuticals ETF shares in Q2 2017, an estimated $615K.
Timber Hill first reported a position in Invesco Pharmaceuticals ETF in Q3 2016 and held it in 3 quarters.
Timber Hill's Invesco Pharmaceuticals ETF position peaked at $615K in Q1 2017.
99 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.